Crédit Industriel et Commercial’s Day One Biopharmaceuticals DAWN Stock Holding History

Crédit Industriel et Commercial’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-135,420	Closed	-$2.9M	–	357
2026 Q1	$2.9M	Buy	+135,420	New	+$1.91M	0.23%	115

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Crédit Industriel et Commercial's DAWN Position: Q2 2026 in Review

Crédit Industriel et Commercial sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 135,420 shares — an estimated $2.9M sold.

Crédit Industriel et Commercial first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $2.9M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Crédit Industriel et Commercial reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Crédit Industriel et Commercial sold 135,420 Day One Biopharmaceuticals shares in Q2 2026, an estimated $2.9M.
Crédit Industriel et Commercial first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Crédit Industriel et Commercial's Day One Biopharmaceuticals position peaked at $2.9M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.